BRUMX | RMFCX | BRUMX / RMFCX | |
Total Expense Ratio | 0.49 | 0.91 | 54% |
Annual Report Gross Expense Ratio | 0.60 | 0.91 | 66% |
Fund Existence | 10 years | 23 years | - |
Gain YTD | 11.614 | 12.767 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 311M | 110B | 0% |
Annual Yield % from dividends | 1.54 | 1.24 | 125% |
Returns for 1 year | 3.53 | 7.96 | 44% |
Returns for 3 years | 25.54 | 32.87 | 78% |
Returns for 5 years | 51.36 | 60.22 | 85% |
Returns for 10 years | 94.28 | 93.48 | 101% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TINRX | 47.05 | -0.07 | -0.15% |
Nuveen Equity Index A | |||
SNOAX | 36.38 | -0.29 | -0.79% |
Easterly Snow Long/Short Opportunity A | |||
FPHAX | 25.63 | -0.21 | -0.81% |
Fidelity Select Pharmaceuticals Port | |||
TRSEX | 19.41 | -0.25 | -1.27% |
Nuveen Quant Small Cap Equity Ret | |||
LRSCX | 15.38 | -0.21 | -1.35% |
Lord Abbett Small Cap Value A |